Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
BAY-0069
Cat. No.:
0225LY-0871
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and HPLC.
Size:
Add to basket
Product Overview
Description:
BAY-0069 is a selective PPARγ transactivator with IC50 values of 6.3 nM for human and 24 nM for murine receptors, making it a viable candidate for oncological research.
Synonym:
420826-65-9; 2-Bromo-N-(2-(4-ethylphenyl)benzo[d]oxazol-5-yl)-5-nitrobenzamide
CAS No.:
420826-65-9
Compound CID:
2298593
Formula:
C22H16BrN3O4
Formula Weight:
466.28
Specification
Targets&IC50:
PPARγ (human): 6.3 nM; CYP2C8: 4.3 μM; PPARγ (rat): 24 nM
Relative Density:
1.530 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
BAY-0069 can be used in drug development research to explore the modulation of specific metabolic targets.
Library Information
Target:
PPAR
Receptor:
PPARγ
Pathways:
Metabolism; DNA damage/DNA repair
Plate Number:
AOCL-12
Plate Location:
b10
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
90 mg/mL; 193.02 mM
